Literature DB >> 12877680

Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype.

Frederic Deschaseaux1, Florelle Gindraux, Rafika Saadi, Laurent Obert, David Chalmers, Patrick Herve.   

Abstract

Human bone marrow mesenchymal stem cells (MSC) generate, via a fibroblast colony-forming unit (CFU-F), osteo-chondroblastic cells as well as adipocytes and stromacytes. To date, these stem cells are isolated indirectly using a cell culture method and phenotyped as CD45 negative while the in vivo counterparts are undetermined. Our aim was to develop a direct selection method and to determine the phenotype of the MSC isolated in this way. Mesenchymal cells were selected with anti-CD49a and/or anti-CD45 antibodies using either flow cytometry or a magnetic beads method. All CFU-F were always detected in the small population of CD49a-positive cells. These CFU retained their differentiation potential and gave rise to osteo-chondroblastic cells, adipocytes and stromacytes. Phenotypic studies on uncultured cells revealed a CD45med,low, CD34low, HLA-II- cell population. Flow cytometry cell sorting showed that MSC with CFU-F potential were obtained only from a CD49a+/CD45med,low population. In addition, when cultured, they clearly became CD45-, CD34-, HLA-II-, CD49a+. These results confirmed that MSC can be directly selected easily from human bone marrow using magnetic beads without altering their differentiation potential. These cells expressed mildly the haematopoietic marker CD45, which was dramatically downregulated by in vitro culture. The expression of CD45 coupled to CD49a thus enabled direct selection of the MSC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12877680     DOI: 10.1046/j.1365-2141.2003.04469.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  33 in total

Review 1.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

Review 2.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.

Authors:  Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

3.  Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells.

Authors:  David A Rider; Thenmozhi Nalathamby; Victor Nurcombe; Simon M Cool
Journal:  J Mol Histol       Date:  2007-08-11       Impact factor: 2.611

4.  Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.

Authors:  Markus Thomas Rojewski; Barbara Maria Weber; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

Review 5.  Strategies for improving the efficacy of bioengineered bone constructs: a perspective.

Authors:  H Petite; K Vandamme; L Monfoulet; D Logeart-Avramoglou
Journal:  Osteoporos Int       Date:  2011-06       Impact factor: 4.507

6.  CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.

Authors:  Selim Kuçi; Zyrafete Kuçi; Hermann Kreyenberg; Erika Deak; Kathrin Pütsch; Sabine Huenecke; Chandrasekhar Amara; Stefanie Koller; Eva Rettinger; Manuel Grez; Ulrike Koehl; Hatixhe Latifi-Pupovci; Reinhard Henschler; Torsten Tonn; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

7.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.

Authors:  Ariane Tormin; Ou Li; Jan Claas Brune; Stuart Walsh; Birgit Schütz; Mats Ehinger; Nicholas Ditzel; Moustapha Kassem; Stefan Scheding
Journal:  Blood       Date:  2011-03-17       Impact factor: 22.113

8.  Stemming the Degeneration: IVD Stem Cells and Stem Cell Regenerative Therapy for Degenerative Disc Disease.

Authors:  V Sivakamasundari; Thomas Lufkin
Journal:  Adv Stem Cells       Date:  2013

9.  Comparative chondrogenesis of human cell sources in 3D scaffolds.

Authors:  R Seda Tigli; Sourabh Ghosh; Michael M Laha; Nirupama K Shevde; Laurence Daheron; Jeffrey Gimble; Menemşe Gümüşderelioglu; David L Kaplan
Journal:  J Tissue Eng Regen Med       Date:  2009-07       Impact factor: 3.963

10.  Management of Liver Failure: From Transplantation to Cell-Based Therapy.

Authors:  Maria Giovanna Francipane; Melchiorre Cervello; Giovanni Battista Vizzini; Giada Pietrosi; Giuseppe Montalto
Journal:  Cell Med       Date:  2011-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.